Jove
Visualize
Contact Us

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

936
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
936
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

866
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
866
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

4.1K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.1K
Analgesia and Pain Management01:25

Analgesia and Pain Management

1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

1.2K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.2K
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

403
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
403
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. Trends In Prenatal Opioid Use Disorder In California, 2010-2022.
  1. Home
  2. Trends In Prenatal Opioid Use Disorder In California, 2010-2022.

Related Experiment Video

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

615

Trends in Prenatal Opioid Use Disorder in California, 2010-2022.

Sidra Goldman-Mellor1, Jyotishman Pathak2, Claire Margerison3

  • 1Department of Public Health, School of Social Sciences, Humanities and Arts, University of California, Merced, Merced, California; Health Sciences Research Institute, University of California, Merced, Merced, California.

American Journal of Preventive Medicine
|September 8, 2025

View abstract on PubMed

Summary
This summary is machine-generated.

The prevalence of prenatal opioid use disorder doubled in California between 2010 and 2022, but most of the increase occurred before fentanyl

More Related Videos

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.6K
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

806

Related Experiment Videos

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

615
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.6K
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

806

Area of Science:

  • Perinatal Health
  • Public Health
  • Epidemiology

Background:

  • Opioid-related deaths in perinatal populations have risen sharply in the U.S.
  • The impact of illicit fentanyl on prenatal opioid use disorder is largely unknown.
  • California experienced a later influx of fentanyl starting in 2019.

Purpose of the Study:

  • To investigate the association between California's fentanyl influx and prenatal opioid use disorder.
  • To analyze trends in opioid use disorder among pregnant individuals in California.

Main Methods:

  • Ecologic, repeated retrospective cohort study of California live-birth deliveries (2010-2022).
  • Utilized statewide, all-payer linked hospitalization and emergency department records.
  • Examined prenatal opioid use disorder prevalence using ICD-9-CM/ICD-10-CM diagnoses and joinpoint/logistic regression.

Main Results:

  • Prenatal opioid use disorder prevalence doubled from 2010-2022 (0.15%-0.30% at delivery; 0.04%-0.08% via ED visits).
  • The majority of the increase occurred before 2018; post-2018 changes were minimal.
  • Disparities in prevalence were noted among non-Hispanic White, other/multiple race individuals, and Medicaid beneficiaries.

Conclusions:

  • Fentanyl's introduction in California was linked to only minor increases in prenatal opioid use disorder.
  • Ongoing monitoring of these trends is crucial for safeguarding perinatal health.